Phase III Clinical Updates
Search documents
Daiichi Sankyo Company, Limited (DSNKY) Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day Transcript
Seeking Alphaยท 2025-12-16 10:30
Group 1 - The event is Daiichi Sankyo's Science and Technology Day 2025, moderated by Kentaro Asakura, Corporate Officer and Head of Corporate Communications [1] - The briefing will be conducted in Japanese and English, with simultaneous interpretation available for participants [2] - Key speakers include Okuzawa (President and CEO), Takeshita (Head of Global R&D), Ken Keller (Director and Head of Global Oncology business), Kashiwase (Head of Global Technology), and Abe (Head of Global) [3]